Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

3-O-Acetyl-16α-hydroxydehydrotrametenolic acid

Copy Product Info
😃Good
Catalog No. TN1109Cas No. 168293-14-9
Alias 3-O-Acetyl-16 alpha-hydroxydehydrotrametenolic acid

3-O-Acetyl-16α-hydroxydehydrotrametenolic acid (3-O-Acetyl-16 alpha-hydroxydehydrotrametenolic acid) exhibits anti-inflammatory activity by inhibiting NO production and iNOS expression in LPS-stimulated Raw264.7 cells.

3-O-Acetyl-16α-hydroxydehydrotrametenolic acid

3-O-Acetyl-16α-hydroxydehydrotrametenolic acid

Copy Product Info
😃Good
Catalog No. TN1109Alias 3-O-Acetyl-16 alpha-hydroxydehydrotrametenolic acidCas No. 168293-14-9
3-O-Acetyl-16α-hydroxydehydrotrametenolic acid (3-O-Acetyl-16 alpha-hydroxydehydrotrametenolic acid) exhibits anti-inflammatory activity by inhibiting NO production and iNOS expression in LPS-stimulated Raw264.7 cells.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$100InquiryInquiry
5 mg$480InquiryInquiry
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
3-O-Acetyl-16α-hydroxydehydrotrametenolic acid (3-O-Acetyl-16 alpha-hydroxydehydrotrametenolic acid) exhibits anti-inflammatory activity by inhibiting NO production and iNOS expression in LPS-stimulated Raw264.7 cells.
In vitro
Based on bioassay-guided fractionation using lipopolysaccharide (LPS)-stimulated Raw264.7 cells, chemical investigation of the EtOH extract of the sclerotia of P. cocos resulted in the isolation and identification of eight compounds including six triterpenoids, namely poricoic acid A (1), 3-O-Acetyl-16 alpha-hydroxydehydrotrametenolic acid(2), polyporenic acid C (3), 3β-hydroxylanosta-7,9(11),24-trien-21-oic acid (4), trametenolic acid (5), and dehydroeburicoic acid (6), as well as (-)-pinoresinol (7) and protocatechualdehyde (8). The structures of the isolated compounds were determined by spectroscopic analysis, including 1H and 13C NMR spectra, and LC/MS analysis. The anti-inflammatory activities of the isolates were evaluated by estimating their effect on the production of nitric oxide (NO) and prostaglandin E2 (PGE2) in LPS-stimulated Raw264.7 as well as on the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Compounds 1-5 inhibited NO production and iNOS expression in LPS-stimulated Raw264.7 cells. Among them, compound 1 exerted the highest anti-inhibitory activity and reduced PGE2 levels via downregulation of COX-2 protein expression.
Synonyms3-O-Acetyl-16 alpha-hydroxydehydrotrametenolic acid
Chemical Properties
Molecular Weight512.72
FormulaC32H48O5
Cas No.168293-14-9
Smiles[H][C@@]12CC=C3C(=CC[C@]4(C)[C@@H]([C@@H](CC\C=C(/C)C)C(O)=O)[C@H](O)C[C@@]34C)[C@@]1(C)CC[C@H](OC(C)=O)C2(C)C
Relative Density.1.12 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy 3-O-Acetyl-16α-hydroxydehydrotrametenolic acid | purchase 3-O-Acetyl-16α-hydroxydehydrotrametenolic acid | 3-O-Acetyl-16α-hydroxydehydrotrametenolic acid cost | order 3-O-Acetyl-16α-hydroxydehydrotrametenolic acid | 3-O-Acetyl-16α-hydroxydehydrotrametenolic acid chemical structure | 3-O-Acetyl-16α-hydroxydehydrotrametenolic acid in vitro | 3-O-Acetyl-16α-hydroxydehydrotrametenolic acid formula | 3-O-Acetyl-16α-hydroxydehydrotrametenolic acid molecular weight